Q3 2023 Holdings
Filed 2023-11-14 | 56 holdings | $749.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immunovant Inc(IMVT) | COM | 45258J102 | $61.4M | 1,600,000 | 8.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $60.7M | 2,250,000 | 8.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $46.2M | 3,743,875 | 6.2% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $40.5M | 1,975,000 | 5.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $36.8M | 1,250,000 | 4.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $30.3M | 600,000 | 4.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $28.5M | 750,000 | 3.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $25.2M | 500,000 | 3.4% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $24.7M | 650,000 | 3.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $24.2M | 200,000 | 3.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $23.4M | 450,000 | 3.1% |
| Icosavax Inc | COM | 45114M109 | $21.4M | 2,765,741 | 2.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $19.5M | 2,180,000 | 2.6% |
| Karuna Therapeutics Inc | COM | 48576A100 | $19.4M | 115,000 | 2.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $16.9M | 150,000 | 2.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $16.1M | 1,050,000 | 2.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.4M | 450,000 | 2.1% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $15.3M | 700,000 | 2.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $14.0M | 1,200,000 | 1.9% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $13.2M | 500,000 | 1.8% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $13.1M | 300,000 | 1.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.5M | 5,300,000 | 1.7% |
| Immatics N.v(IMTX) | SHS | N44445109 | $12.2M | 1,050,000 | 1.6% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $11.9M | 5,032,501 | 1.6% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $10.6M | 4,650,000 | 1.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $10.5M | 400,000 | 1.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $9.2M | 400,000 | 1.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.7M | 900,000 | 1.2% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $7.8M | 225,000 | 1.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $7.4M | 250,000 | 1.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $7.3M | 2,525,000 | 1.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $7.0M | 950,000 | 0.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $6.9M | 250,000 | 0.9% |
| Morphosys AG | SPONSORED ADS | 617760202 | $6.4M | 950,000 | 0.9% |
| Repare Therapeutics Inc(RPTX)Call | COM | 760273102 | $6.0M | 500,000 | 0.8% |
| Geron Corp(GERN) | COM | 374163103 | $5.8M | 2,750,000 | 0.8% |
| Merus N V | COM | N5749R100 | $5.8M | 245,000 | 0.8% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $4.8M | 1,000,000 | 0.6% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.8M | 310,000 | 0.6% |
| Iovance Biotherapeutics Inc(IOVA)Call | COM | 462260100 | $4.6M | 1,000,000 | 0.6% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $4.2M | 1,044,444 | 0.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $4.2M | 307,076 | 0.6% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.1M | 544,960 | 0.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.7M | 125,000 | 0.5% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $3.6M | 300,000 | 0.5% |
| Verve Therapeutics Inc | COM | 92539P101 | $2.9M | 215,000 | 0.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $2.8M | 424,000 | 0.4% |
| Aeglea Biotherapeutics Inc(SYRE) | COM NEW | 00773J202 | $2.6M | 210,000 | 0.3% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $1.3M | 115,000 | 0.2% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $1.0M | 188,390 | 0.1% |